Dimpy P. Shah, MD, PhD, of the Mays Cancer Center, was quoted in a story about a study that shows nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose.

Read more

The post CTV News: Study suggests 94 percent of cancer patients develop COVID-19 antibody response after full vaccination appeared first on UT Health San Antonio.